Though the baseline illness severity was uneven, with more severe patients in the itolizumab arm, the medication showed great ...

Ulcerative colitis affects daily life, but proper management can help maintain quality of life. Learn how to cope with this ...

Mirikizumab showed superior maintenance efficacy over most treatments for ulcerative colitis (UC), according to a network ...

Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company leveraging a deep understanding of immunobiology to ...

Equillium, Inc. (NASDAQ:EQ), a biotechnology company with a market capitalization of $25.15 million and current stock price of $0.71, announced today the positive outcomes of their Phase 2 clinical ...

Resilience has characterized many people who have dealt with chronic health challenges, and it would be hard to find someone ...

Chronic ulcerative colitis probably was first described in 1875 by Wilks and Moxon 4 in their lectures on pathologic anatomy. This report makes no mention of whether there was simultaneous ...

Janus kinase (JAK) inhibitors can quickly and effectively manage ulcerative colitis (UC), especially when more conventional treatments haven’t worked. UC is a type of inflammatory bowel disease ...

A new test developed in the UK can accurately predict whether high-risk patients will develop bowel cancer, also known as ...

Equillium (EQ) and Biocon announced topline results from the Phase 2 study evaluating itolizumab in the treatment of moderate to severe ...